Concern arises from the increased use of fructose and high-fructose corn syrup as a sweetener.
Researchers in Switzerland and Belgium reviewed the evidence.
Here’s what we know. Continue reading Dietary fructose and the risk of metabolic diseases
Concern arises from the increased use of fructose and high-fructose corn syrup as a sweetener.
Researchers in Switzerland and Belgium reviewed the evidence.
Here’s what we know. Continue reading Dietary fructose and the risk of metabolic diseases
Diets and dietary supplements are often used by people with multiple sclerosis (MS).
This updated Cochrane review reports on studies of dietary habits as an effective treatment for MS patients. Continue reading Diets for multiple sclerosis
Researchers in France participating in the GuidAge Study Group assessed the long-term use of standardized ginkgo biloba extract in elderly adults with memory complaints. Continue reading Ginkgo biloba fails to prevent Alzheimer’s disease
Only a third of patients with depression respond fully to antidepressant drugs, and little evidence exists regarding the best next-step treatment for patients with resistant symptoms.
Researchers in the CoBalT study (Cognitive Behavioural Therapy) at the University of Bristol in England examined cognitive behavioral therapy (CBT) as an adjunct to usual care (including pharmacotherapy) for primary care patients with treatment-resistant depression compared with usual care alone. Continue reading A role for cognitive behavioral therapy in treatment-resistant depression